The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.
November 12th 2024
Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Multimodality breast cancer screening shows possible boon for high-risk women
December 4th 2009Breast cancer detection rates increase substantially when women at high risk and those with dense breasts undergo mammography and ultrasound annually, according to a study presented Wednesday at the 2009 RSNA meeting. MRI is an even more effective technique when used with mammography, but only for women who are at high risk for the condition.
Mammo image enhancer firm aims for OEMs
December 3rd 2009RSNA newbie Real-Time Tomography launched at this year’s meeting a new image processing and enhancement software library for digital mammography. But the product, dubbed Adara, will not be sold to providers, at least not directly. Real-Time Tomography came to Chicago with hopes of attracting original equipment manufacturers to its library.
Presence of MQSA facilities correlates with lower breast cancer mortality rates
December 2nd 2009Using sophisticated mapping technology, census data, and state cancer registry statistics, researchers from Georgia established a link between the presence of Mammography Quality Standards Act-certified mammography centers and lower death rates from breast cancer.
Breast MRI assesses tumor size the best prior to surgery, post-treatment
December 2nd 2009MRI is the best method to assess breast cancer tumor size prior to surgery and after chemotherapy, according to findings from the American College of Radiology Imaging Network trial 6657. Size on mammography does not correlate with true residual disease in patients treated with neoadjuvant chemotherapy and thus MRI is the best modality, the researchers said.
Digital mammo plus breast MRI proves clinically beneficial, but not cost-effective
December 1st 2009Digital mammography plus MRI is the most clinically effective strategy for screening women carrying a genetic mutation known to increase the risk for breast cancer. However, unless the cost of breast MRI decreases substantially, the modality doesn’t translate as cost-effective, according to a study presented on Tuesday at the RSNA 2009 meeting.
Better QA procedures help eliminate breast errors
November 30th 2009Developing a structured and rigorous peer-review quality assurance process that involves ongoing case presentations, open discussion, and consensus opinions can help to decrease perception errors and improve the interpretive skills of breast imagers, according to radiologists at Beth Israel Deaconess Medical Center in Boston.
Size alone should not determine biopsy decision, RSNA study finds
November 29th 2009Radiologists will often not biopsy small lesions because they assume the lesions are benign. But the decision to do so could mean missing malignant cases, according to a scientific session presented Sunday at the RSNA 2009 meeting.
Breast imagers join backlash against new mammography guidelines
November 19th 2009Powerful political sources are lining up with radiologists and mammographers against guidelines from a federal panel that scrap longstanding policies for the timing of screening mammography. Even the U.S. Department of Health and Human Services is distancing itself from its panel’s recommendations in the wake of criticism from many women’s health advocates and breast cancer survivors.
Federal panel says screening mammography should begin at 50; experts outraged
November 16th 2009The U.S. Preventive Services Task Force has issued a recommendation against routine breast cancer screening for women ages 40 to 49 and suggests the screening interval should be changed from every year to every two years beginning at age 50. The new recommendations will result in “many needless deaths,” said a joint statement from the American College of Radiology and the Society of Breast Imaging
Economics, not race, explains delay in mammography follow-up
November 11th 2009African American women take longer to come in for follow-up care after a suspicious breast abnormality is found, according to a study from the University of South Carolina. The problem may have more to do with economics than race, according to a physician with extensive clinical experience with this unique patient population.
Digital mammo proves better than film-screen for diagnosing DCIS
November 10th 2009The largest population-based study to date comparing filmscreen mammography and full-field digital mammography has found the digital approach is superior for visualizing microcalcifications deemed crucial to diagnosing ductal carcinoma in situ.
Computer-aided detection software backs up coronary CTA interpretation
November 9th 2009Computer-aided detection software developed especially for coronary CT angiography could boost imagers’ ability to detect clinically relevant stenosis in patients at low to moderate risk of coronary artery disease, according to researchers at the Medical University of South Carolina.
Women who skip regular mammograms run greater risk of dying from breast cancer
October 28th 2009A long-term study of breast imaging in Massachusetts has confirmed what mammographers have argued for years: older adult women who do not receive regular screening mammography are far more likely to die of breast cancer than women who routinely undergo the procedure.
Blood test monitors breast cancer treatment effectiveness
September 16th 2009With the goal of tailoring cancer interventions for the individual, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have published the results of a prospective study that validates the use of a simple blood test to help doctors more reliably assess treatment effectiveness for patients with metastatic breast cancer.